News Contact Us Careers Get E-Mail alerts Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

See below for our most recent and archived news events.

Click below for current and archived news related to the company.

ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update

May 11, 2022 4:05pm EDT

ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022

May 04, 2022 7:00am EDT

ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV™ at CIS 2022

Apr 01, 2022 7:00am EDT

ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 Months

Mar 25, 2022 7:00am EDT

ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management

Mar 24, 2022 4:05pm EDT

ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022

Mar 21, 2022 7:00am EDT

ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA

Mar 07, 2022 4:05pm EST

ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update

Jan 19, 2022 7:00am EST

ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC

Jan 18, 2022 7:00am EST

ADMA Biologics Adopts Limited Duration Stockholder Rights Plan

Dec 21, 2021 7:00am EST

1
2
3
4
5
6
7
8
9
10
...23